Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

M Carbone, PS Adusumilli… - CA: a cancer journal …, 2019 - Wiley Online Library
Mesothelioma affects mostly older individuals who have been occupationally exposed to
asbestos. The global mesothelioma incidence and mortality rates are unknown, because …

The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future

JM Foster, C Zhang, S Rehman… - CA: A Cancer …, 2023 - Wiley Online Library
Peritoneal metastasis (PM) is often regarded as a less frequent pattern of spread; however,
collectively across all spectra of primary tumors, the consequences of PM impact a large …

Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical …

JM Foster, R Sleightholm, A Patel, V Shostrom… - JAMA network …, 2019 - jamanetwork.com
Importance Currently, rates of referral of patients with peritoneal metastasis in the United
States who qualify for cytoreductive surgery combined with hyperthermic intraperitoneal …

[HTML][HTML] Malignant peritoneal mesothelioma: a review

J Kim, S Bhagwandin, DM Labow - Annals of translational medicine, 2017 - ncbi.nlm.nih.gov
Mesothelioma is a malignancy of serosal membranes. It is most commonly encountered in
the visceral pleura with the second most common location in the peritoneum. The diagnosis …

Advances in the management of peritoneal malignancies

V Kepenekian, A Bhatt, J Peron, M Alyami… - Nature Reviews …, 2022 - nature.com
Peritoneal surface malignancies (PSMs) are usually associated with a poor prognosis.
Nonetheless, in line with advances in the management of most abdominopelvic metastatic …

Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up

S Kusamura, V Kepenekian, L Villeneuve… - European Journal of …, 2021 - Elsevier
Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis,
treatment and follow-up - ScienceDirect Skip to main contentSkip to article Elsevier logo …

[HTML][HTML] Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives

S Boussios, M Moschetta, A Karathanasi… - Annals of …, 2018 - ncbi.nlm.nih.gov
Malignant peritoneal mesothelioma (MPM) is a rare disease with a wide clinical spectrum. It
arises from the peritoneal lining and commonly presents with diffuse, extensive spread …

Effects of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy and neoadjuvant intraperitoneal/systemic chemotherapy on peritoneal metastases …

Y Yonemura, H Ishibashi, M Hirano, A Mizumoto… - Annals of surgical …, 2017 - Springer
Abstract Background The Peritoneal Cancer Index (PCI) is the most important prognostic
factor following comprehensive treatment for peritoneal metastasis (PM) from gastric cancer …

Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma

XC Fang, L Shu, TL Chen, XL Zhao, LC Yang, T Dou… - Molecular Cancer, 2024 - Springer
Background Malignant peritoneal mesothelioma (MPM) is an extremely rare and highly
invasive tumor. Due to the lack of accurate models that reflect the biological characteristics …

Malignant peritoneal mesothelioma: an in-depth and up-to-date review of pathogenesis, diagnosis, management and future directions

JB Karpes, R Shamavonian, S Dewhurst, E Cheng… - Cancers, 2023 - mdpi.com
Simple Summary Mesothelioma is a malignancy of mesothelial tissues. The majority arise
from the pleura, but approximately thirty percent of cases arise from the peritoneum …